BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9581849)

  • 1. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells.
    Scholl S; Müller R; Clement JH; Loncarevic IF; Böhmer FD; Höffken K
    Leuk Res; 2006 May; 30(5):633-42. PubMed ID: 16473406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells.
    Ito Y; Mishra NC; Yoshida K; Kharbanda S; Saxena S; Kufe D
    Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
    Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells.
    Benito A; Grillot D; Nuñez G; Fernández-Luna JL
    Am J Pathol; 1995 Feb; 146(2):481-90. PubMed ID: 7856757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.
    Okuda K; Matulonis U; Salgia R; Kanakura Y; Druker B; Griffin JD
    Exp Hematol; 1994 Oct; 22(11):1111-7. PubMed ID: 7925778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
    Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M
    Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
    Jiang XH; Lam SK; Lin MC; Jiang SH; Kung HF; Slosberg ED; Soh JW; Weinstein IB; Wong BC
    Oncogene; 2002 Sep; 21(39):6113-22. PubMed ID: 12203123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
    Cheng G; Meinkoth JL
    Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2.
    Chen CY; Faller DV
    Oncogene; 1995 Oct; 11(8):1487-98. PubMed ID: 7478573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
    Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
    J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.
    Flanagan SA; Meckling KA
    Cancer Chemother Pharmacol; 2003 May; 51(5):363-75. PubMed ID: 12736759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines.
    Cioca DP; Aoki Y; Kiyosawa K
    Cancer Gene Ther; 2003 Feb; 10(2):125-33. PubMed ID: 12536201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.